Literature DB >> 4098730

Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma.

U Abildgaard, M K Fagerhol, O Egeberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4098730     DOI： 10.3109/00365517009046245

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN： 0036-5513            Impact factor:   1.713


× No keyword cloud information.
  14 in total

1.  Pleiotropic effects of antithrombin strand 1C substitution mutations.

Authors:  D A Lane; R J Olds; J Conard; M Boisclair; S C Bock; M Hultin; U Abildgaard; H Ireland; E Thompson; G Sas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Inherited antithrombin-III deficiency causing mesenteric venous infarction: a new clinical entity.

Authors:  J C Gruenberg; R C Smallridge; R D Rosenberg
Journal:  Ann Surg       Date:  1975-06       Impact factor: 12.969

Review 3.  Anticoagulants in anaesthesia.

Authors:  P J Stow; F A Burrows
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

4.  [Endogenous inhibitors of fibrinolytic activity in liver cirrhosis (author's transl)].

Authors:  R Aschauer; F Holzknecht; S Platzer
Journal:  Klin Wochenschr       Date:  1973-12-01

5.  Standardisation of a simple method for the determination of antithrombin activity.

Authors:  A Frigola
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

6.  Antithrombin-3 deficiency in a Dutch family.

Authors:  J van der Meer; E A Stoepman-van Dalen; J M Jansen
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

7.  A method for the differential determination of plasma antithrombins.

Authors:  V Musumeci; A Vincenti; B Bizzi
Journal:  J Clin Pathol       Date:  1976-01       Impact factor: 3.411

8.  Cloning and expression of the cDNA for human antithrombin III.

Authors:  S C Bock; K L Wion; G A Vehar; R M Lawn
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

9.  Antithrombin III metabolism in patients with liver disease.

Authors:  E Knot; J W Ten Cate; H R Drijfhout; L H Kahlé; G N Tytgat
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

10.  Blood coagulation studies in patients with advanced carcinoma of the prostate treated with 2,6-cis-diphenylhexamethylcyclotetrasiloxane or estramustine-17-phosphate.

Authors:  M Blombäck; F Edsmyr; C Kockum; C Paul
Journal:  Urol Res       Date:  1978
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.